🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 16 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/06/2005 28,40 28,50 27,40 27,90 +0,00% 3,87% 6.400
29/06/2005 29,70 29,90 27,50 27,90 -5,42% 8,08% 10.480
28/06/2005 30,00 30,00 29,50 29,50 +1,37% 1,67% 5.360
27/06/2005 30,90 30,90 29,00 29,10 -3,00% 6,15% 6.320
24/06/2005 30,50 30,50 28,70 30,00 +1,01% 5,90% 6.160
23/06/2005 30,60 30,60 29,70 29,70 -1,98% 2,94% 18.760
22/06/2005 32,80 32,80 29,50 30,30 -5,31% 10,06% 24.640
21/06/2005 30,00 32,00 29,50 32,00 +10,96% 8,33% 41.440
20/06/2005 28,80 29,10 27,60 28,84 +2,27% 5,21% 17.150
17/06/2005 26,30 28,50 26,30 28,20 +7,22% 8,37% 13.350
16/06/2005 24,80 26,30 24,80 26,30 +6,91% 6,05% 9.710
15/06/2005 25,80 25,80 24,50 24,60 +0,41% 5,04% 4.530
14/06/2005 24,70 24,80 24,00 24,50 +3,81% 3,24% 8.460
13/06/2005 24,40 26,00 23,50 23,60 -1,67% 10,25% 19.430
10/06/2005 24,00 24,50 23,50 24,00 +2,39% 4,17% 8.290
09/06/2005 24,00 24,80 23,00 23,44 -3,93% 7,50% 6.560
08/06/2005 22,40 24,50 20,30 24,40 +14,02% 18,75% 40.460
07/06/2005 23,30 23,30 20,90 21,40 -4,46% 10,30% 34.610
06/06/2005 25,20 26,30 22,40 22,40 -8,57% 15,48% 28.870
03/06/2005 25,20 25,20 24,10 24,50 -2,78% 4,37% 7.630
02/06/2005 25,30 26,30 25,00 25,20 -3,45% 5,14% 10.710
01/06/2005 28,10 28,10 25,80 26,10 -4,74% 8,19% 9.420
31/05/2005 26,30 27,80 26,30 27,40 +5,38% 5,70% 16.680
27/05/2005 25,40 26,19 25,30 26,00 +3,17% 3,50% 3.710
26/05/2005 25,00 25,20 24,00 25,20 +0,00% 4,80% 4.350
25/05/2005 25,50 25,70 24,36 25,20 +6,33% 5,25% 7.610
24/05/2005 25,00 25,50 23,70 23,70 -7,06% 7,20% 15.170
23/05/2005 26,30 26,50 25,00 25,50 -1,92% 5,70% 6.070
20/05/2005 26,40 26,40 25,40 26,00 +0,00% 3,79% 12.870
19/05/2005 26,00 26,30 25,50 26,00 +4,00% 3,08% 6.610